Literature DB >> 4022942

Temporal changes in the utilization of amniocentesis for prenatal diagnosis by women of advanced maternal age, 1976-1983.

P A Baird, A D Sadovnick, B C McGillivray.   

Abstract

Utilization of amniocentesis for prenatal diagnosis because of the indication of advanced maternal age (greater than or equal to 35 years at delivery) was examined in the population of B.C. over an 8-year period (1976-1983). As of 1983, approximately one out of three eligible women (greater than or equal to 35 years at delivery) is having the test. In the older group (greater than or equal to 38 years at delivery) approximately one out of two eligible women is having the test. The data do not indicate that the proportion of eligible women having amniocentesis has reached a plateau; utilization is continuing to increase. It appears that prenatal diagnosis is an ethically acceptable alternative for a large proportion of the population.

Entities:  

Mesh:

Year:  1985        PMID: 4022942     DOI: 10.1002/pd.1970050305

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

1.  Effect of chorionic villus sampling and early pregnancy counselling on uptake of prenatal diagnosis.

Authors:  P D Knott; R H Ward; M K Lucas
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  Prenatal genetic counselling.

Authors:  B C McGillivray
Journal:  Can Fam Physician       Date:  1986-10       Impact factor: 3.275

3.  A retrospective survey of community based utilization of Tay Sachs screening in Eight New Jersey counties.

Authors:  R Wallerstein; K Seshadri; S Brady-Yasbin; L Y Shih; D F Wallerstein
Journal:  J Genet Couns       Date:  1994-06       Impact factor: 2.537

4.  Frequency of births with potentially avoidable serious chromosomal anomalies in EEC countries, 1979-1982.

Authors:  L P Ten Kate; H Dolk; M C Cornel; P De Wals; G J Te Meerman; M F Lechat; J A Weatherall
Journal:  J Epidemiol Community Health       Date:  1988-09       Impact factor: 3.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.